Building our Biofuture: Policy issues and opportunities for next generation biotechnologies


Livija Deban


Chief Scientific Officer


Livija leads the strategic and operational development of Prokarium's immuno-oncology portfolio, focused on bioengineering Living Cures for solid tumors. Before joining Prokarium in 2018, she led the lead selection and immuno-oncology R&D at Oxford BioTherapeutics, focusing on target discovery and the development of immunomodulatory antibodies for cancer treatment. Livija conducted her academic research at Cancer Research UK and holds a PhD in Basic and Applied Immunology.

This speaker will talk about

Find here the list of all the sessions presented by this speaker in order not to miss any of it.